Immunomodulatory inhibition of osteoclastogenesis by a marine microalgal ethanol fraction targeting T-cells, antigen presentation, and macrophage fate
BackgroundTargeting immune pathways to prevent bone loss represents a promising, yet underexplored therapeutic strategy.MethodsAn ethanol-soluble fraction derived from the freeze-dried biomass of the marine microalga Skeletonema costatum (SKLT) was tes…